Ab-68

N/A

Report date: 2023/01/07 20:44:14

Base Information

Drug NameAb-68
Drug Alias NameAb-68
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-E2
TargetsHepatitis C virus E2 glycoprotein
Therapy Area/IndicationsFibrosisMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMount Sinai School Of Medicine
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsFibrosisMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A